| Size | Price | Stock | Qty |
|---|---|---|---|
| 250mg |
|
||
| 500mg |
|
||
| Other Sizes |
| Targets |
Glufosinate-ammonium targets glutamine synthetase, a key enzyme in nitrogen metabolism. It inhibits this enzyme, leading to the accumulation of toxic levels of ammonia in plant cells, which ultimately causes plant death. It is a racemic mixture of D- and L-isomers.
|
|---|---|
| ln Vitro |
In neural stem cells (NSCs), glufosinate (1-100 μM; 12DIV) destroys intercellular traces of secreted V-SVZ [2]. Celsr2 gene RT-PCR at 100 μM is significantly decreased by glufosinate (1-100 μM; 12DIV) [2].
In vitro, Glufosinate-ammonium inhibits glutamine synthetase activity. It is a potent inhibitor of this enzyme. Its herbicidal activity is based on this mechanism. It also has neurotoxic activity. |
| ln Vivo |
The maternal toxicity of 50 or 250 mg/kg of glufosinate (10-250 mg/kg; gavage; daily; on days 6–15 of gestation) was observed in Wistar rats [3]. In female musk deer, the half-life is shorter than 4 hours [3].
In vivo, Glufosinate-ammonium is effective as a herbicide for controlling a wide range of weeds. It is applied to plants, where it is absorbed and translocated, leading to plant death. It is also used as a desiccant. |
| Enzyme Assay |
In vitro enzyme/receptor binding assays for Glufosinate-ammonium involve measuring its inhibition of glutamine synthetase activity. These assays typically use purified enzyme preparations and appropriate substrates to determine the inhibitory potency.
|
| Cell Assay |
RT-PCR [2]
Cell Types: Ependymal cells Tested Concentrations: 1, 3, 10, 100 μM Incubation Duration: 12DIV (NSCs -to) expression[2]. -Ependymal cell time point) Experimental Results: Celsr2 gene expression was Dramatically diminished at 100 μM. In vitro cell-based assays for Glufosinate-ammonium are not typically performed, as it is a herbicide. Its effects on plant cells are studied using whole-plant assays. Its neurotoxic effects may be studied in neuronal cell cultures. |
| Animal Protocol |
In vivo animal experiments for Glufosinate-ammonium are not typically performed for herbicidal purposes. However, its toxicity has been studied in animals as part of safety assessments. It is a neurotoxin.
|
| ADME/Pharmacokinetics |
Metabolism / Metabolites
The main metabolite in urine and feces is 3-[hydroxy(methyl)phosphono]propionic acid. In plants, glufosinate degradation involves deamination, decarboxylation, and ultimately β-oxidation to produce carbon dioxide. Biological Half-Life …A 65-year-old male ingested BASTA containing 20% (w/v) glufosinate… The changes in serum glufosinate concentration showed a Tα of 1.84 hours and a Tβ of 9.59 hours. /BASTA/ Glufosinate-ammonium is a highly soluble white to light yellow crystalline solid with a slightly pungent odor. Exposure occurs by inhalation, ingestion, or contact. Specific pharmacokinetic data is not provided. |
| Toxicity/Toxicokinetics |
Toxicity Summary
Glufosinate irreversibly inhibits glutamine synthase, thereby reducing ammonia detoxification capacity. Elevated ammonia levels lead to impaired photorespiration and photosynthesis in plants. (T10) Toxicity Data LC50 (Rat) = 1,260 mg/m3 Non-human Toxicity Values LD50 Rats (Male) Oral 2000 mg/kg LD50 Rats (Female) Oral 1620 mg/kg Mouse (Male) Oral 431 mg/kg Mouse (Female) Oral 416 mg/kg For more non-human toxicity values (complete data) for glufosinate-ammonium salts (11 in total), please visit the HSDB records page. Glufosinate-ammonium is a neurotoxin. It is a synthetic organophosphate compound. Its use as a pesticide is regulated due to its toxicity. It is characterized as a hazardous substance. |
| References |
|
| Additional Infomation |
2-Amino-4-[hydroxy(methyl)phosphoryl]butyric acid is a non-protein α-amino acid, formed by substituting a hydroxy(methyl)phosphoryl group at the 4-position of 2-aminobutyric acid. It belongs to the phosphonic acid class and is also a non-protein α-amino acid. Glufosinate is a metabolite found or produced in Escherichia coli (strains K12 and MG1655). Glufosinate has been reported to exist in Streptomyces hygroscopicus and Streptomyces viride, with relevant data available. Glufosinate or its ammonium salt DL-phosphinic acid is the active ingredient in many non-selective systemic herbicides, such as Basta, Rely, Finale, Ignite, Challenge, and Liberty. It interferes with the glutamine biosynthesis pathway, which binds to the glutamate binding site of the enzyme. Plants treated with glufosinate die due to ammonia accumulation and glutamine deficiency leading to the cessation of photosynthesis.
Mechanism of Action …Glufosinate is a structural analogue of glutamate, which exerts its effects in plants by inhibiting glutamine synthase, leading to the complete breakdown of ammonia metabolism. Due to the structural similarity between glufosinate and glutamate, its effects on various glutamate utilization systems in mammals need to be investigated. Although glufosinate inhibits glutamine synthase activity in different tissues in laboratory animals, this inhibition only leads to slight increases in glutamate and ammonia levels at high sublethal and lethal doses. After 28 days of oral administration, glufosinate had no effect on glutathione and carbohydrate metabolism, or on the biosynthesis of non-essential amino acids in rats and dogs. In vitro experiments showed that glufosinate does not interfere with multiple neurotransmitter receptors, and intravenous injection does not affect tissue concentrations of catecholamine neurotransmitters. These results indicate that…in mammals, inhibition of glutamine synthase activity in various tissues does not lead to the disruption of ammonia metabolism. Mammalian metabolism…compensates for the inhibition of glutamine synthase activity through various other metabolic pathways… Glufosinate-ammonium is a broad-spectrum herbicide that inhibits glutamine synthetase. It is a neurotoxin and is used for total vegetation control. It is a racemic mixture and is not approved for medical use. |
| Molecular Formula |
C5H15N2O4P
|
|---|---|
| Molecular Weight |
198.15
|
| Exact Mass |
215.103
|
| CAS # |
77182-82-2
|
| Related CAS # |
Glufosinate;51276-47-2
|
| PubChem CID |
4794
|
| Appearance |
White to off-white solid powder
|
| Boiling Point |
519.1ºC at 760 mmHg
|
| Melting Point |
210°C
|
| Flash Point |
100 °C
|
| LogP |
0.244
|
| Hydrogen Bond Donor Count |
3
|
| Hydrogen Bond Acceptor Count |
5
|
| Rotatable Bond Count |
4
|
| Heavy Atom Count |
11
|
| Complexity |
193
|
| Defined Atom Stereocenter Count |
0
|
| InChi Key |
IAJOBQBIJHVGMQ-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C5H12NO4P/c1-11(9,10)3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)(H,9,10)
|
| Chemical Name |
2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid
|
| Synonyms |
HOE-00661; HOE 00661; Glufosinate-ammonium
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
H2O : ~250 mg/mL (~1261.61 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: 100 mg/mL (504.64 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.
 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 5.0467 mL | 25.2334 mL | 50.4668 mL | |
| 5 mM | 1.0093 mL | 5.0467 mL | 10.0934 mL | |
| 10 mM | 0.5047 mL | 2.5233 mL | 5.0467 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.